Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus

被引：0
|
作者：
Udaya M. Kabadi
机构：
[1] University of Iowa,Department of Medicine
[2] Endocrinology,undefined
[3] Veterans Affairs Medical Center,undefined
来源：
Clinical Drug Investigation | 2008年 / 28卷
关键词：
Glycaemic Control; Insulin Glargine; Insulin Aspart; Insulin Detemir; Hypoglycaemic Event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and objective: Iowa Care (Iowa Medicaid), USA, switched insulin glargine to insulin detemir in subjects with diabetes mellitus without the approval of healthcare providers. This study set out to examine the impact of transition on parameters of diabetes management in type 1 diabetes.
引用
收藏
页码：697 / 701
页数：4
相关论文
共 50 条
  • [1] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Kabadi, Udaya M.
    [J]. CLINICAL DRUG INVESTIGATION, 2008, 28 (11) : 697 - 701
  • [2] Deleterious outcomes on abrupt transition from insulin glargine to detemir in type 1 DM
    Kabadi, U. M.
    [J]. DIABETOLOGIA, 2008, 51 : S391 - S391
  • [3] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Yoshiki Kusunoki
    Tomoyuki Katsuno
    Kana Miyakoshi
    Takashi Ikawa
    Rie Nakae
    Fumihiro Ochi
    Masaru Tokuda
    Takafumi Akagami
    Kazuki Murai
    Masayuki Miuchi
    Tomoya Hamaguchi
    Jun-ichiro Miyagawa
    Mitsuyoshi Namba
    [J]. Diabetes Therapy, 2013, 4 : 461 - 472
  • [4] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    [J]. DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [5] ECONOMIC ANALYSIS OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Acevedo, G. A. R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A408 - A409
  • [6] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    [J]. DIABETOLOGIA, 2011, 54 : S420 - S421
  • [7] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [8] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
  • [9] EFFICACY OF INSULIN DEGLUDEC AFTER SWITCHING FROM INSULIN GLARGINE OR INSULIN DETEMIR IN YOUNG PERSONS WITH TYPE 1 DIABETES
    Urakami, T.
    Kuwabara, R.
    Habu, M.
    Okuno, M.
    Suzuki, J.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S235 - S236
  • [10] COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL
    Pichon-Riviere, A.
    Caporale, J. E.
    von Schulz-Hausmann, C.
    Augustovski, F. A.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A505 - A505
12345